Loading...
•
Dec 31, 2020
DexCom Q4 2020 Earnings Report
Dexcom's Q4 2020 financial results were reported, showing revenue growth and strategic advancements.
Key Takeaways
Dexcom reported a strong Q4 2020 with a 23% increase in revenue to $568.9 million compared to the same quarter of the prior year. GAAP operating income was $104.0 million, representing 18.3% of revenue.
Revenue grew by 23% to $568.9 million compared to Q4 2019.
U.S. revenue increased by 20%, while international revenue grew by 35%.
GAAP operating income was $104.0 million, or 18.3% of revenue.
GAAP net income was $355.2 million, or $3.48 per diluted share.
DexCom
DexCom
DexCom Revenue by Segment
DexCom Revenue by Geographic Location
Revenue by Segment
Sensor and other Revenue
CapyFin.comHardware Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The company is reiterating guidance for fiscal year 2021 revenue, and establishing guidance for full year gross profit, operating margin, and Adjusted EBITDA margin as follows: Revenue of approximately $2.21 - 2.31 billion (15-20% growth), Non-GAAP Gross profit margin of approximately 65%, Non-GAAP Operating margin of approximately 13%, Adjusted EBITDA margin of approximately 23%
Positive Outlook
- Revenue of approximately $2.21 - 2.31 billion (15-20% growth)
- Non-GAAP Gross profit margin of approximately 65%
- Non-GAAP Operating margin of approximately 13%
- Adjusted EBITDA margin of approximately 23%
Revenue & Expenses
Visualization of income flow from segment revenue to net income